Mercado mundial de antibióticos y antimicrobianos para animales: tendencias de la industria y pronóstico hasta 2031

Análisis y tamaño del mercado de antibióticos y antimicrobianos para animales

El mercado de antibióticos y antimicrobianos para animales continúa evolucionando, con el objetivo de reducir la resistencia y mejorar la eficacia. Los avances incluyen nuevas formulaciones y sistemas de administración, que enfatizan la seguridad y el cumplimiento normativo. Tecnologías como la cría de precisión y las herramientas genómicas están transformando las estrategias de tratamiento. El crecimiento está impulsado por el aumento de la producción ganadera y los estrictos estándares de salud. La innovación continua garantiza prácticas sostenibles en medio de las preocupaciones sanitarias mundiales.

El tamaño del mercado mundial de antimicrobianos y antibióticos para animales se valoró en USD 2.56 mil millones en 2023 y se proyecta que alcance los USD 3.64 mil millones para 2031, con una CAGR del 4,50% durante el período de pronóstico de 2024 a 2031. Además de los conocimientos sobre escenarios de mercado como el valor de mercado, la tasa de crecimiento, la segmentación, la cobertura geográfica y los principales actores, los informes de mercado seleccionados por Data Bridge Market Research también incluyen un análisis profundo de expertos, epidemiología de pacientes, análisis de canalización, análisis de precios y marco regulatorio.

Alcance del informe y segmentación del mercado       

Market Definition

Animal antimicrobials and antibiotics refer to medications used in veterinary medicine to treat and prevent bacterial infections in animals. These drugs are crucial for maintaining animal health and welfare in agriculture, companion animals, and wildlife conservation. However, their use requires careful management to prevent antibiotic resistance and ensure food safety. Regulatory frameworks govern their use to promote responsible antibiotic stewardship in animal populations.

Animal Antimicrobials and Antibiotics Market Dynamics

Drivers

• Increasing Demand for Animal Protein

The increasing global demand for animal protein, driven by population growth and dietary shifts towards higher protein intake, fuels the need for antibiotics in livestock. These medications are crucial for preventing and treating diseases, ensuring uninterrupted production of meat, milk, and eggs. For instance, in intensive poultry farming, antibiotics are essential to control infections such as avian influenza, maintaining the health and productivity of large-scale poultry operations worldwide.

• Rising Incidences of Animal Diseases

The rising incidence of infectious diseases in livestock poses significant threats to health and productivity, driving the demand for antibiotics. For example, outbreaks of avian influenza and foot-and-mouth disease necessitate immediate intervention to prevent widespread economic losses in poultry and livestock sectors. Antibiotics play a crucial role in controlling these outbreaks, ensuring animal welfare and sustaining agricultural productivity, thereby driving growth in the animal antimicrobials and antibiotics market.

Opportunities

• Technological Advancements in Veterinary Medicine

Technological advancements in veterinary medicine, such as advanced diagnostic tools and precision treatments, are creating opportunities in the antibiotics and antimicrobials market. For instance, the development of rapid diagnostic tests enables early detection of diseases, facilitating targeted antibiotic use. Additionally, innovations in vaccine development offer preventative solutions, reducing the reliance on antibiotics. These advancements not only improve animal health outcomes but also drive demand for more effective and specialized antimicrobial products.

• Increased Investments in Animal Healthcare

Increased investments in animal healthcare, particularly by pharmaceutical companies and agricultural stakeholders, present significant opportunities in the antibiotics market. These investments fuel research and development efforts aimed at developing new formulations and therapies that enhance animal health outcomes. For instance, collaborations between veterinary experts and pharmaceutical firms have led to innovative antibiotics that effectively combat emerging diseases in livestock, thereby expanding the market's product offerings and capabilities.

Restraints/Challenges

• Concern of Antibiotic Resistance

Increased use of antibiotics in animal agriculture fuels antibiotic-resistant bacteria, posing severe risks through foodborne transmission and undermining antibiotic efficacy in veterinary and human medicine. This threat amplifies public health concerns, limiting treatment options and complicating disease management. Regulatory pressures and consumer awareness drive stringent measures, challenging traditional farming practices reliant on antibiotics. Addressing these issues demands substantial changes in agricultural practices and heightened vigilance in antibiotic stewardship.    

• Complex Supply Chain and Distribution Issues

The complex supply chain and distribution issues in the animal antimicrobials market pose significant challenges. Varied regulatory demands across regions complicate logistics, potentially delaying access to essential products. This logistical complexity and regulatory disparity hinder market efficiency, exacerbating difficulties in ensuring proper distribution and administration of antimicrobials across diverse farming operations.   

This market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Impact and Current Market Scenario of Raw Material Shortage and Shipping Delays

Data Bridge Market Research offers a high-level analysis of the market and delivers information by keeping in account the impact and current market environment of raw material shortage and shipping delays. This translates into assessing strategic possibilities, creating effective action plans, and assisting businesses in making important decisions.

Apart from the standard report, we also offer in-depth analysis of the procurement level from forecasted shipping delays, distributor mapping by region, commodity analysis, production analysis, price mapping trends, sourcing, category performance analysis, supply chain risk management solutions, advanced benchmarking, and other services for procurement and strategic support.

Expected Impact of Economic Slowdown on the Pricing and Availability of Products

When economic activity slows, industries begin to suffer. The forecasted effects of the economic downturn on the pricing and accessibility of the products are taken into account in the market insight reports and intelligence services provided by DBMR. With this, our clients can typically keep one step ahead of their competitors, project their sales and revenue, and estimate their profit and loss expenditures.

Recent Developments

• In July 2020, Trianni Inc. (USA) and Zoetis (USA) initiated a collaboration aimed at developing transgenic monoclonal antibody platforms to innovate veterinary medications. This partnership seeks to leverage Trianni's expertise in antibody discovery and Zoetis's leadership in animal health solutions. The FDA recently approved Zoetis's acquisition of Marboquin (USA), marking a strategic move to bolster their portfolio and capabilities in the veterinary pharmaceutical sector.

Animal Antimicrobials and Antibiotics Market Scope

The market is segmented on the basis of product type, mode of delivery and animal. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Product Type

• Tetracycline
• Penicillin
• Sulfonamide
• Macrolide
• Cephalosporin
• Fluoroquinolone
• Aminoglycosides
• Lincosamides

 Mode of Delivery

• Premixes
• Oral Powder
• Oral solutions
• Premixes
• Injection

 Animal

• Food-Producing Animals
  • Cattle
  •  Pigs
  •  Poultry
  • Sheep and Goats
  • Other
• Companion Animals
  • Dogs
  •  Cats
  • Horses
  • Other

Animal Antimicrobials and Antibiotics Market Regional Analysis/Insights

The market is analyzed and market size insights and trends are provided by country, product type, mode of delivery and animal as referenced above.

The countries covered in the market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America is expected to dominate the animal antimicrobials and antibiotics market due to its burgeoning animal population, expanding pet insurance sector, increasing demand for animal-derived foods, and rising expenditures on animal health. These factors collectively drive growth in the region's veterinary pharmaceuticals market.

Se espera que Asia-Pacífico sea testigo de la CAGR más alta en el mercado de antimicrobianos y antibióticos para animales debido a la creciente población animal de la región y la creciente demanda de productos alimenticios de origen animal. Esta tendencia refleja una mayor conciencia y adopción de prácticas de atención médica veterinaria para garantizar la salud y la productividad de los animales en las diversas economías de la región.

La sección de países del informe también proporciona factores de impacto de mercado individuales y cambios en la regulación en el mercado a nivel nacional que afectan las tendencias actuales y futuras del mercado. Los puntos de datos como el análisis de la cadena de valor aguas abajo y aguas arriba, las tendencias técnicas y el análisis de las cinco fuerzas de Porter, los estudios de casos son algunos de los indicadores utilizados para pronosticar el escenario del mercado para países individuales. Además, la presencia y disponibilidad de marcas globales y sus desafíos enfrentados debido a la competencia grande o escasa de las marcas locales y nacionales, el impacto de los aranceles nacionales y las rutas comerciales se consideran al proporcionar un análisis de pronóstico de los datos del país.

Análisis del panorama competitivo y de la cuota de mercado de los antimicrobianos y antibióticos para uso animal

El panorama competitivo del mercado proporciona detalles por competidor. Los detalles incluidos son una descripción general de la empresa, las finanzas de la empresa, los ingresos generados, el potencial de mercado, la inversión en investigación y desarrollo, las nuevas iniciativas de mercado, la presencia global, los sitios e instalaciones de producción, las capacidades de producción, las fortalezas y debilidades de la empresa, el lanzamiento de productos, la amplitud y variedad de productos, y el dominio de las aplicaciones. Los puntos de datos anteriores proporcionados solo están relacionados con el enfoque de las empresas en relación con el mercado.

Algunos de los principales actores que operan en el mercado son:

• Zoetis Services LLC (Estados Unidos)
• Boehringer Ingelheim International GmbH (Alemania)
• Merck & Co., Inc. (Estados Unidos)
•  Eli Lilly and Company (Estados Unidos)
• Bayer AG (Alemania)
• Dechra Pharmaceuticals Limited (Reino Unido)
•  Virbac (Francia)
• Vetoquinol (Francia)
• Sanofi (Francia)
• Elanco (Estados Unidos)
• Endovac Salud Animal (Estados Unidos)
• ECO - Animal Health Ltd. (Reino Unido)
• Productos inmunológicos indios Ltd. (India)
• Ashish Ciencias de la Vida (India)
•  Lutim Pharma Private Limited (India)

SKU-61243